IMAGING
1 min.Read

Envista Announces DEXIS Brand Name for Imaging Business

DEXIS: Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced Envista’s KaVo imaging business will be re-branded as “DEXIS”.

Dental professionals have known the DEXIS brand as the leader in digital intraoral radiography and diagnostic software innovation for over 20 years. The DEXIS brand will now represent a full portfolio of award-winning imaging and digital solutions including cone-beam computed tomography (CBCT), handheld x-rays, intraoral scanners, sensors, and navigated surgical solutions.

DEXIS will combine other leading brands including i-CAT, Gendex, Instrumentarium, SOREDEX, and NOMAD, which with DEXIS are pioneers in x-ray generation, digital intraoral radiography, panoramic and cephalometric imaging, and 3D CBCT imaging. We have one of the largest installed bases of dental imaging devices in the industry with over 150,000 imaging devices currently utilized in dental practices. End-users of imaging devices can utilize our new diagnostics and treatment planning software suite DTX Studio to access all clinical patient images in one place, using one software.

Envista Holdings Corporation CEO Amir Aghdaei said, “We are excited to unite our imaging portfolio under the DEXIS brand and unveil our new DEXIS logo that will be featured on our entire imaging portfolio. This is one step in our continued efforts to create integrated, digital workflows that connect all our products and enable dental professionals to treat and improve more patient lives. We are living out our strategy to digitize, personalize, and democratize dentistry and look forward to the future.”

Headquartered in the United States, DEXIS is present in over 50 countries and has a workforce of approximately 1,000 employees. Over the rest of 2022, the imaging portfolio will transition in branding from KaVo to DEXIS with different schedules by product and by region. DEXIS continues to value its distributor partnerships and is excited to partner with distributors around the world to bring end-to-end, digital, diagnostic workflow solutions to dental professionals.

SourceEnvista Holdings Corporation

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330